» » Climacteric Medicine - Where Do We Go?: Proceedings of the 4th Workshop of the International Menopause Society

Download Climacteric Medicine - Where Do We Go?: Proceedings of the 4th Workshop of the International Menopause Society fb2

by Hermann P.G. Schneider,Frederick Naftolin
Download Climacteric Medicine - Where Do We Go?: Proceedings of the 4th Workshop of the International Menopause Society fb2
Medicine
  • Author:
    Hermann P.G. Schneider,Frederick Naftolin
  • ISBN:
    1842142615
  • ISBN13:
    978-1842142615
  • Genre:
  • Publisher:
    Informa Healthcare; 1 edition (October 20, 2004)
  • Pages:
    256 pages
  • Subcategory:
    Medicine
  • Language:
  • FB2 format
    1884 kb
  • ePUB format
    1523 kb
  • DJVU format
    1180 kb
  • Rating:
    4.3
  • Votes:
    277
  • Formats:
    doc lrf azw txt


Key feature Addresses the wide range of advances in clinical practice for the climacteric Provides current opinion and information on the use of HRT in perimenopausal .

Climacteric Medicine-Where Do We Go? Proceedings of the 4th Workshop of the International Menopause Society. 1842142615 (ISBN13: 9781842142615).

Climacteric medicine – where do we go? Section IV Rationale for and availability of therapeutic hormones 13. .With this Workshop, the International Menopause Society is attempting to raise a global voice of contemporary clinical judgement and psychological sanity.

Climacteric medicine – where do we go? Section IV Rationale for and availability of therapeutic hormones 13 Pharmacology during the menopausal transition M. Notelovitz. The contributions of the Workshop, by tradition, have been collected for publication in these Workshop Proceedings.

Proceedings of the 4th Workshop of the International

Proceedings of the 4th Workshop of the International. by H. P. G. Schneider. WHILA) study; 6 Adequately assessed quality of life; 7 Quality of life: the Asian perspective; 8 Alternatives to hormone therapy in menopausal women.

Professor, Department of Obstetrics and Gynecology University of Pennsylvania School of Medicine (4.Climacteric Medicine - Where Do We Go?: Proceedings of the 4th Workshop of the International Menopause Society. ISBN 978-0-203-02496-6.

Professor, Department of Obstetrics and Gynecology University of Pennsylvania School of Medicine (4 October 2003). Hormone Use in Menopause and Male Andropause : A Choice for Women and Men: A Choice for Women and Men. Oxford University Press, USA. pp. 73–. ISBN 978-0-19-803620-3.

Based on the 4th IMS Workshop, this book addresses the advances in clinical practice for the climacteric. The major focus is on a re-evaluation of existing HRT agents and the development of a future consensus for climacteric Medicine. Section I: Natural History.

The following is a table of clinically used progestogens by decade of introduction, adapted, with .

The following is a table of clinically used progestogens by decade of introduction, adapted, with additions and corrections, from Schneider & Naftolin (2004):.

At the end of the 5th. year, the independent drug safety monitoring board . Women at the end of their reproductive age often complain of climacteric symptoms which can be quite debilitating at times. year, the independent drug safety monitoring board (DSMB) terminated the. estrogen + progestin arm of the study because of an apparent increase in the risk. In Schneider HPG, Naftolin F, eds. Climacteric Medicine – Where Do We Go? Proceedings of the 4th Workshop of the. International Menopause Society.

At a time when ongoing research and clinical investigation into the use of HRT in perimenopausal women are incomplete--and when certain controversies remain unresolved--this summary of current opinion and knowledge fills the need for authoritative reference on this topic. Written by a 'Blue Ribbon' panel, the book addresses the wide range of advances in clinical practice for the climacteric in diagnostic technology and to therapeutic choices. In order to provide optimal assistance in determining an individual women's risk-profile --and properly to assess the potential of therapeutic intervention--the biological and practical rationale of all existing HRT agents are reviewed. Key feature*Addresses the wide range of advances in clinical practice for the climacteric *Provides current opinion and information on the use of HRT in perimenopausal women *Reviews the biological and practical rationale of all existing HRT agents